Review



brca1 associated protein 1 bap1 status  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology brca1 associated protein 1 bap1 status
    FIGURE 6. HLA class I expression inversely associates with intratumoral NK cell percentages. (A) Bar plots showing the percentages of HLA class I–positive tumor cells (top) and the NK cells (middle) and CD8 T cells (bottom) of all immune cells per patient. (B) Box plot showing the percentage of HLA class I–positive tumor cells versus the <t>BAP1</t> staining that was performed on tissue. (C) Box plot showing the percentage of HLA class I–positive tumor cells versus the risk group. (D) Kaplan–Meier plot showing the RFS of two groups of patients, separated by the median percentage of NK cells into NKhigh and NKlow groups.
    Brca1 Associated Protein 1 Bap1 Status, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 709 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brca1+associated+protein+1+bap1+status/pm39918475-52-3-22?v=Santa+Cruz+Biotechnology
    Average 96 stars, based on 709 article reviews
    brca1 associated protein 1 bap1 status - by Bioz Stars, 2026-07
    96/100 stars

    Images

    1) Product Images from "Transvitreal Retinochoroidal Biopsies of Primary Uveal Melanoma Reveal an Association of Low HLA Class I and High NK Cell Abundance in Low-Risk Disease."

    Article Title: Transvitreal Retinochoroidal Biopsies of Primary Uveal Melanoma Reveal an Association of Low HLA Class I and High NK Cell Abundance in Low-Risk Disease.

    Journal: Investigative ophthalmology & visual science

    doi: 10.1167/iovs.66.2.24

    FIGURE 6. HLA class I expression inversely associates with intratumoral NK cell percentages. (A) Bar plots showing the percentages of HLA class I–positive tumor cells (top) and the NK cells (middle) and CD8 T cells (bottom) of all immune cells per patient. (B) Box plot showing the percentage of HLA class I–positive tumor cells versus the BAP1 staining that was performed on tissue. (C) Box plot showing the percentage of HLA class I–positive tumor cells versus the risk group. (D) Kaplan–Meier plot showing the RFS of two groups of patients, separated by the median percentage of NK cells into NKhigh and NKlow groups.
    Figure Legend Snippet: FIGURE 6. HLA class I expression inversely associates with intratumoral NK cell percentages. (A) Bar plots showing the percentages of HLA class I–positive tumor cells (top) and the NK cells (middle) and CD8 T cells (bottom) of all immune cells per patient. (B) Box plot showing the percentage of HLA class I–positive tumor cells versus the BAP1 staining that was performed on tissue. (C) Box plot showing the percentage of HLA class I–positive tumor cells versus the risk group. (D) Kaplan–Meier plot showing the RFS of two groups of patients, separated by the median percentage of NK cells into NKhigh and NKlow groups.

    Techniques Used: Expressing, Staining



    Similar Products

    brca1 associated protein 1 bap1 status  (Santa Cruz Biotechnology)
    96
    Santa Cruz Biotechnology brca1 associated protein 1 bap1 status
    FIGURE 6. HLA class I expression inversely associates with intratumoral NK cell percentages. (A) Bar plots showing the percentages of HLA class I–positive tumor cells (top) and the NK cells (middle) and CD8 T cells (bottom) of all immune cells per patient. (B) Box plot showing the percentage of HLA class I–positive tumor cells versus the <t>BAP1</t> staining that was performed on tissue. (C) Box plot showing the percentage of HLA class I–positive tumor cells versus the risk group. (D) Kaplan–Meier plot showing the RFS of two groups of patients, separated by the median percentage of NK cells into NKhigh and NKlow groups.
    Brca1 Associated Protein 1 Bap1 Status, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brca1+associated+protein+1+bap1+status/pm39918475-52-3-22?v=Santa+Cruz+Biotechnology
    Average 96 stars, based on 1 article reviews
    brca1 associated protein 1 bap1 status - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    FIGURE 6. HLA class I expression inversely associates with intratumoral NK cell percentages. (A) Bar plots showing the percentages of HLA class I–positive tumor cells (top) and the NK cells (middle) and CD8 T cells (bottom) of all immune cells per patient. (B) Box plot showing the percentage of HLA class I–positive tumor cells versus the BAP1 staining that was performed on tissue. (C) Box plot showing the percentage of HLA class I–positive tumor cells versus the risk group. (D) Kaplan–Meier plot showing the RFS of two groups of patients, separated by the median percentage of NK cells into NKhigh and NKlow groups.

    Journal: Investigative ophthalmology & visual science

    Article Title: Transvitreal Retinochoroidal Biopsies of Primary Uveal Melanoma Reveal an Association of Low HLA Class I and High NK Cell Abundance in Low-Risk Disease.

    doi: 10.1167/iovs.66.2.24

    Figure Lengend Snippet: FIGURE 6. HLA class I expression inversely associates with intratumoral NK cell percentages. (A) Bar plots showing the percentages of HLA class I–positive tumor cells (top) and the NK cells (middle) and CD8 T cells (bottom) of all immune cells per patient. (B) Box plot showing the percentage of HLA class I–positive tumor cells versus the BAP1 staining that was performed on tissue. (C) Box plot showing the percentage of HLA class I–positive tumor cells versus the risk group. (D) Kaplan–Meier plot showing the RFS of two groups of patients, separated by the median percentage of NK cells into NKhigh and NKlow groups.

    Article Snippet: To identify the BRCA1 associated protein 1 (BAP1) status of tumors, a standard immunohistochemistry (IHC) staining using 1:100 anti-BAP1 (clone C-4, sc-28383; Santa Cruz Biotechnology, Dallas, TX, USA) was performed.

    Techniques: Expressing, Staining